News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Global crude rose about 3% to near $109 after US-China talks ended without a joint peace roadmap, stoking supply-disruption concerns.
  • Energy-market volatility rose as broader Middle East tensions stayed unresolved despite a 45-day Israel-Lebanon ceasefire extension.
  • U.S. antitrust authorities opened an inquiry into Arm's CPU licensing to assess potential market monopolization.
  • South Korean regulators launched parallel probes of Arm's local offices.
  • Fitch cut Goldman Sachs BDC's outlook to negative, flagging a thin asset coverage cushion and rising non-accruals.
  • Fitch's action raises credit risk concerns for BDC investors and could pressure leveraged-loan valuations.

Latest Articles

Emails Indicate Prince Andrew Sent Official UK Trade Reports to Jeffrey Epstein

Emails Indicate Prince Andrew Sent Official UK Trade Reports to Jeffrey Epstein

Emails contained in a newly released batch of documents indicate that Andrew Mountbatten-Windsor forwarded official British trade reports to Jeffrey Epstein in 2010 after receiving them in his capacity as a government trade envoy. The disclosure has renewed scrutiny of the former royal, prompted police reviews and intensified a political controvers…

Standard Chartered Names Raza Jafree to Lead Global Private Client Sales as Bank Forms Wealth-CIB Partnership

Standard Chartered Names Raza Jafree to Lead Global Private Client Sales as Bank Forms Wealth-CIB Partnership

Standard Chartered has appointed Raza Jafree as global head of private client sales as the bank establishes a new partnership between its corporate and investment bank and wealth unit to support single-family offices and ultra-high net worth clients. Jafree, who joined on February 2 from UBS and is based in Hong Kong, brings almost 30 years of expe…

Jakarta Stocks Close Higher; IDX Composite Advances 0.92%

Jakarta Stocks Close Higher; IDX Composite Advances 0.92%

Indonesia's benchmark IDX Composite finished higher after Monday's session, led by gains in the Infrastructure, Agriculture and Basic Industry sectors. Market breadth favored advancers, with several individual stocks recording double-digit percentage moves. Oil and currency markets moved lower while gold futures rose.

Unilever Shares Surpass Bank Target as Deutsche Bank Lowers Rating to Hold

Unilever Shares Surpass Bank Target as Deutsche Bank Lowers Rating to Hold

Deutsche Bank downgraded Unilever Plc to 'hold' from 'buy' after the stock climbed past the bank's unchanged 5150p target. Analyst Tom Sykes noted the shares now trade at roughly 19x forward 12-month earnings, a 19% premium to the market, and that Unilever's valuation versus sector peers is at or near record highs. While the bank continues to ackno…

Citizens Upgrades TPG to Market Outperform, Sets $75 Target as Diversification and Fundraising Strengthen Profile

Citizens Upgrades TPG to Market Outperform, Sets $75 Target as Diversification and Fundraising Strengthen Profile

Citizens Financial analyst Brian McKenna upgraded TPG Inc. (NASDAQ:TPG) from Market Perform to Market Outperform and set a $75 price target, citing successful execution of a diversified strategy since the company’s public listing in early 2022. Citizens highlighted organic growth across multiple product lines, strategic acquisitions including Angel…

Novo Nordisk Rises After Hims Withdraws $49 Compounded Weight-Loss Pill

Novo Nordisk Rises After Hims Withdraws $49 Compounded Weight-Loss Pill

Novo Nordisk shares jumped sharply in Copenhagen after telehealth company Hims Hers Health pulled a newly launched $49 compounded weight-loss pill that used semaglutide, following pressure from Novo and the U.S. Food and Drug Administration. The FDA said it will tighten oversight of compounded GLP-1 products, and Novo confirmed it will pursue legal…

Takaichi’s Electoral Sweep Hands Mandate, But Markets Will Define Her Limits

Takaichi’s Electoral Sweep Hands Mandate, But Markets Will Define Her Limits

Japan’s landslide parliamentary victory for Prime Minister Sanae Takaichi’s Liberal Democratic Party gives her a strong political foothold to pursue an expansionary economic agenda. Markets reacted with equity rallies but have held back decisive moves in bonds and the yen pending clarity on how new measures will be funded and whether policymakers w…

Rising Labour Costs Drive Up January Bankruptcies in Japan, Survey Finds

Rising Labour Costs Drive Up January Bankruptcies in Japan, Survey Finds

A private survey shows Japan saw a rise in corporate bankruptcies in January, driven in part by higher labour costs and worsening labour shortages among smaller businesses. Separate government data indicated real wages fell 0.1% in December from a year earlier, improving from a steeper drop in November. Policymakers face a dilemma: lift pay to sust…

Novo Nordisk Stock Climbs After Hims & Hers Pulls $49 Semaglutide Compound

Novo Nordisk Stock Climbs After Hims & Hers Pulls $49 Semaglutide Compound

Novo Nordisk’s Frankfurt-listed shares gained 4.5% on Monday following Hims & Hers’ decision to stop selling a $49 compounded weight-loss pill based on semaglutide after legal warnings from Novo and action from U.S. regulators. The move followed earlier signals from the FDA that it would crack down on unauthorized compounded GLP-1 medications. Desp…